IMR Press / EJGO / Volume 35 / Issue 2 / DOI: 10.12892/ejgo24072014

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Contraception after breast cancer: a retrospective review of the practice among French Gynecologists in the 2000’s
Show Less
1 Centre des maladies du sein, Hôpital Saint Louis, AP-HP, Paris
2 Groupe d’Etude et de Réflexion sur les Mastopathies, Hôpital Saint Louis, AP-HP, Paris
3 Société Française de Gynécologie; 4Fédération Nationale des Collèges de Gynécologie Médicale, Paris (France)
Eur. J. Gynaecol. Oncol. 2014, 35(2), 149–153;
Published: 10 April 2014

Purpose of investigation: To describe the French practices regarding contraception after breast cancer in the 2000’s. Materials and Methods: A total of 2,500 forms were sent to gynecologists practicing in France. Inclusion criteria were premenopausal patients who had a history of breast cancer and who had been prescribed contraception after diagnosis. Between June 1, 2002 and January 1, 2003, 197 evaluable responses were retrieved. Results: The median age of the sample was 38.5 years. The most commonly used form of contraception was an intrauterine device (n = 144, 73.1%). Hormonal contraception was prescribed for 42 patients (21.3%), and other methodswere used in 29 patients (14.7%) (Condoms n = 14, tubal sterilization n = 7, and others n = 8). Recurrence occurred in 27 patients (13%); 2.9% in the progestin group, 16.3% in the IUD group, and 14.8% with the other methods). Conclusions: It is necessary to evaluate current contraception practices after breast cancer to evaluate the efficacy and safety of contraception in these patients.
Breast cancer
Levonorgestrel IUD-intra uterine device
Back to top